NCT00138606View on ClinicalTrials.gov

Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Novartis Investigative Site, Investigative Centers

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY